Allylation of Erythromycin Derivatives: Introduction of Allyl Substituents into Highly Hindered Alcohols

Journal of Organic Chemistry

Volumn 68, Issue 23, 2003, Pages 8847-8852

  Stoner, Eric J ^a   Peterson, Matthew J ^a,b   Allen, Michael S ^a   DeMattei, John A ^a,c   Haight, Anthony R ^a   Leanna, M Robert ^a   Patel, Subhash R ^a   Plata, Daniel J ^a   Premchandran, Ramiya H ^a,d   Rasmussen, Michael ^a  

^a ABBOTT LABORATORIES   (United States)

^b THERAVANCE INC   (United States)

^c ARRAY BIOPHARMA INC   (United States)

^d Sarawak MediChem Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATES; CATALYSIS; SUBSTITUTION REACTIONS;

ETHER-FORMING PROTOCOLS;

AROMATIC COMPOUNDS;

2 PROPANOL; ALCOHOL; ALKENE; CARBAMIC ACID DERIVATIVE; CARBONIC ACID DERIVATIVE; CLARITHROMYCIN; ERYTHROMYCIN DERIVATIVE; ETHER; PALLADIUM; TERT BUTYL CARBONATE; UNCLASSIFIED DRUG;

ALLYLATION; ARTICLE; CATALYSIS; DRUG RESEARCH; DRUG STRUCTURE;

ALCOHOLS; ALKYLATION; ERYTHROMYCIN;

EID: 10744225142     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo034883z     Document Type: Article

References (56)

1. Flynn, E. H.; Sigal, M. V., Jr.; Wiley, P. F.; Gerzon, K. J. Am. Chem. Soc. 1954, 76, 3121.
2. (a) Charles, L.; Segretti, J. Drugs 1997, 53 (3), 349.
3. (b) Clark, R. F.; Ma, Z.; Wang, S.; Griesgraber, G.; Tufano, M.; Yong, H.; Li, L.; Zhang, X.; Nilius, A. M.; Chu, D. T. W.; Or, Y. S. Biorg. Med. Chem. Lett. 2000, 10 (8), 815.
4. (a) Ball, P.; Baquero, F.; Cars, O.; File, T.; Garau, J.; Klugman, K.; Low, D. E.; Rubinstein, E.; Wise, R. J. Antimicrobial Chem. 2002, 49 (1), 31.
5. (b) Blondeau, J. M.; DeCarolis, E.; Metzler, K. L.; Hansen, G. T. Expert Opin. Investig. Drugs 2002, 11 (2), 189.
6. (a) Klein, L. L.; Freiberg, L. A.; Kurath, P.; Henry, R. F. J. Org. Chem. 1993, 58 (11), 3209.
7. (b) Burnelle-Curty, C.; Faghih, R.; Pagano, T.; Henry, R. F.; Lartey, P. A. J. Org. Chem. 1996, 61 (15), 5153.
8. Another solution is the conversion of the ring to an azalactone via Beckmann rearrangement as in azithromycin: Yang, B. V.; Goldsmith, M.; Rizzi, J. P. Tetrahedron Lett. 1994, 35 (19), 3025.
9. For an excellent review of ketolide chemistry and activity see: Ma, Z.; Nemoto, P. A. Curr. Med. Chem.-Anti-Infective Agents 2002, 1 (1), 15.
10. (a) Or, Y. S.; Clark, R. F.; Wang, S.; Chu, D. T. W.; Nilius, A. M.; Flamm, R. K.; Mitten, M.; Ewing, P.; Alder, J.; Ma, Z. J. Med. Chem. 2000, 43 (6), 1045.
11. (b) Or, Y. S.; Ma, Z.; Clark, R. F.; Chu, D. T.; Plattner, J. J.; Griesgraber, G. U.S. Patent 5,866,549, 1999.
12. (a) Watanabe, Y.; Morimoto, S.; Adachi, T.; Kashimura, M.; Asaka, T. J. Antibiotics 1993, 46 (4), 647.
13. (b) Morimoto, S.; Adachi, T.; Matsunaga, T.; Kashimura, M.; Asaka, T.; Watanabe, Y.; Sota, K.; Sekiuchi, K. U.S. Patent 4,990,602, 1991.
14. (c) Morimoto, S.; Misawa, Y.; Adachi, T.; Nagate, T.; Watanabe, Y.; Omura, S. J. Antibiotics 1990, 43 (5), 286.
15. For an improved synthesis of ABT-773 incorporating this chemistry, see: Plata, D. J.; Leanna, M. R.; Rasmussen, M.; McLaughlin, M. A.; Condon, S. L.; Kerdesky, F. A. J.; King, S. A.; Peterson, M. A.; Stoner, E. J.; Wittenberger, S. J., submitted.
16. (a) Stoner, E. J.; Peterson, M. J.; Ku, Y.-Y.; Cink, R. D.; Cooper, A. J.; Deshpande, M., N.; Grieme, T.; Haight, A. R.; Hill, D. R.; Hsu, M. C.-P.; King, S. A.; Leanna, M. R.; Lee, E. C.; McLaughlin, M. A.; Morton, H. E.; Napier, J. J.; Plata, D. J.; Raje, P. R.; Rasmussen, M.; Riley, D.; Tien, J. J.-H. J.; Wittenberger, S. J. U.S. Patent 6,437,106, 2002.
17. (b) Allen, M. S.; Premchandran, R. H.; Chang, S.-J.; Condon, S.; DeMattei, J. A.; King, S. A.; Kolackowski, L.; Manna, S.; Nichols, P. J.; Patel, H. H.; Patel, S. R.; Plata, D. J.; Stoner, E. J.; Tien, J. J.-H. J.; Wittenberger, S. J. U.S. Patent 6,579,986, 2002.
18. (a) Comprehensive Asymmetric Catalysis; Jacobsen, E. N., Pfaltz, A., Yamamoto, H., Eds.; Springer: Berlin, 1999; Vol 2.
19. (b) Trost, B. M.; Van Vranken, D. L. Chem Rev. 1996, 96 (1), 395.
20. (c) Shibasaki, M. In Advances in Metal-Organic Chemistry; Liebeskind, L. S., Ed.; JAI Press: Greenwich, 1996; Vol. 5.
21. (d) Tsuji, J. Palladium Reagents and Catalysts: Innovations in Organic Synthesis; John Wiley and Sons: New York, 1995.
22. (e) Harrington, P. J. In Comprehensive Organometallic Chemistry II; Abel, E. W. Stone, F. G. A., Wilkinson, G., Eds.; Pergamon Press: Oxford, 1995; Vol. 12, pp 798-903
23. (a) Larock, R. C.; Lee, N. H. Tetrahedron Lett. 1991, 32 (44), 6315.
24. (b) Muzart, J.; Genet, J.-P.; Denis, A. J. Organomet. Chem. 1987, 326 (1), C23.
25. (a) Burke, S. D.; Jiang, L. Org. Lett. 2001, 3, 1953.
26. (b) Vares, L.; Rein, T. Org. Lett. 2000, 2 (17), 2611.
27. (c) Labrosse, J.-R.; Poncet, C.; Lhoste, P.; Sinou, D. Tetrahedron Asym. 1999, 10, 1069.
28. (d) Fournier-Nguefack, C.; Lhoste, P.; Sinou, D. J. Chem. Res. (S) 1998, 105.
29. (e) Thorey, C.; Wilken, J.; Henin, F.; Martens, J.; Mehler, T.; Muzart, J. Tetrahedron Lett. 1995, 36, 5527.
30. (f) Massacret, M.; Goux, C.; Lhoste, P.; Sinou, D. Tetrahedron Lett. 1994, 35, 6093.
31. (g) Trost, B. M.; McEachern, E. J.; Toste, F. D. J. Am. Chem. Soc. 1998, 120, 12702.
32. (h) Cuiper, A. D.; Kellogg, R. M. Chem. Commun. 1998, 655
33. (a) Lakhmiri, R.; Lhoste, P.; Sinou, D. Tetrahedron Lett. 1989, 30 (35), 4669.
34. (b) Lakhmiri, R.; Lhoste, P.; Sinou, D. Synth. Commun. 1990, 20 (10), 1551.
35. (c) Kumar, V.; Gopalakrishnan, V.; Ganesh, K. N. Bull. Chem. Soc. Jpn. 1992, 65 (6), 1665.
36. (d) Lakhmiri, R.; Lhoste, P.; Kryczka, B.; Sinou, D. J. Carbohydr. Chem. 1993, 12 (2), 223.
37. (e) Lakhmiri, R.; Lhoste, P.; Boullanger, P.; Sinou, D. J. Chem. Res. (S) 1990, 342.
38. An alternative approach is incorporation of the desired alcohol in the allyl carbonate: Oltvoort, J. J.; Kloosterman, M.; VanBoom, J. H. Recl. Trav. Chim. Pays-Bas 1983, 102, 501.
39. Reviews of π-allyl palladium chemistry (a) Trost, B. M. Acc. Chem. Res. 1980, 13 (11), 386.
40. (b) Tsuji, J. Tetrahedron 1986, 42 (16), 4361.
41. Commercially available.
42. Brettle, R.; Khan, M. A. J. Chem. Res. 1989, 1, 240.
43. Tsuji, J.; Shimizu, I.; Minami, I.; Ohashi, Y.; Sugiura, T.; Takahashi, K. J. Org. Chem. 1985, 50, 1523.
44. Goto, H.; Kawashima, Y.; Kashimura, M.; Morimoto, S.; Osawa, E. J. Chem. Soc., Perk. Trans 2 1993, 1647. The results obtained by these computational methods are consistent with observed experimental data in ref 11.
45. (a) Haight, A. R.; Stoner, E. J.; Peterson, M. J.; Grover, V. J. Org. Chem. 2003, 68, 8092-8096.
46. (b) Another application of this chemistry has been published based on prior verbal communication: Marmsäter, F. P.; Vanecko, J. A.; West, F. G. Tetrahedron 2002, 58 (10), 2027.
47. Erythromycin A oxime (E and Z isomers): (a) Egan, R. S.; Freiberg, L. A. ; Washburn, W. H. J. Org. Chem. 1974, 39 (17), 2492,
48. (b) Massey, E. H.; Kittchell, B.; Marti, L. D.; Gerzon, K.; Murphy, H. W. Tetrahedron Lett. 1970, 11 (2), 157.
49. (c) Hatton, I. K.; Tyler, J. W. Tetrahedron Lett. 1989, 30 (5), 605.
50. Reviews of selectivities and basic aspects of π-allyl palladium chemistry: (a) Tsuji, J. Pure Appl. Chem. 1989, 61 (10), 1673.
51. (b) Trost, B. M. Angew. Chem., Int. Ed. Eng. 1989, 28, 1173.
52. 2: Amatore, C.; Jutand, A.; M'Barki, M. A. Organometallics 1992, 11 (9), 3009.
53. 3P as ligand: dppb is preferred.
54. Houlihan, F.; Bouchard, F.; Frèchet, J. M. J.; Willson, C. G. Can. J. Chem. 1985, 63, 153.
55. (a) Glase, S. A.; Akunne, H. C.; Heffner, T. G.; Jaen, J. C.; MacKenzie, R. G.; Meltzer, L. T.; Pugsley, T. A.; Smith, S. J.; Wise, L. D. J. Med. Chem. 1996, 39 (16), 3179.
56. (b) Yamanaka, H.; Shiraiwa, M.; Edo, K.; Sakamoto, T. Chem. Pharm. Bull. 1979, 27 (1), 270.